object
enicepatide (CT-388)
Experimental once-weekly injectable targeting GLP-1 and GIP receptors for obesity and type 2 diabetes.
Most often with
- workClinicalTrials.gov 1
- placeNew Delhi 1
- placeBasel 1
- personTeresa Graham 1
- personLevi Garraway 1
- organisationZealand Pharma 1
- organisationU.S. Food and Drug Administration 1
- organisationRoche 1
- organisationReuters 1
- organisationNovo Nordisk 1
- organisationMedical Daily 1
- organisationFood and Drug Administration 1
- organisationEli Lilly 1
- organisationCarmot Therapeutics 1
- organisationBMO Capital Markets 1
- organisationBioSpace 1